Growth hormone pens

Which growth hormone pen is right for my child?

For children who need daily growth hormone injections, improvements and advancements in device design have made a big difference. Today, there are pens with many different useful features to choose from. To help you and your doctor choose the device that best suits your child's individual needs, it's worth considering the sort of features you would look for in an injection device. For example: 

  • How easy will the device be to inject, and how easy will it be to learn? 
  • Would you prefer a device that can hide the needle?
  • Is the device lightweight and easy to hold?

Why the right device matters

Making sure your child takes his/her growth hormone every day is one of the key ways of ensuring a successful outcome of the treatment. Research suggests that 3 factors can help encourage people to take their growth hormone injections regularly:

  • A simple injection device
  • An easy-to-learn injection technique
  • Minimising injection pain and anxiety  



FlexPro® is the latest prefilled pen from Novo Nordisk that offers a new delivery experience for users.

Learn more about FlexPro®



NordiFlex® helps make injections easier as it comes ready to use. No reconstitution or loading is necessary.

Learn more about NordiFlex®



NordiPen® is one of the most widely used durable GHT pens in the world. It is simple, accurate and convenient to use.

Learn more about NordiPen®



NordiLet® is a prefilled easy-to-use device. A flexible pen for a more flexible life.

Learn more about NordiLet®


FlexPro®, NordiFlex®, NordiPen®, and NordiLet® are registered trademarks of Novo Nordisk Health Care AG.

Availability of Novo Nordisk growth hormone devices and strengths varies by country.

Important Note: The content of this website is not intended to be a substitute for professional medical advice, diagnosis or treatment. Do not disregard your doctor's advice or delay in seeking it because of something you have read in this website.

HQMMA/NT/0815/0140(1)   September 2018